Form 8-K - Current report:
SEC Accession No. 0001104659-25-051136
Filing Date
2025-05-21
Accepted
2025-05-20 18:42:42
Documents
13
Period of Report
2025-05-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515582d1_8k.htm   iXBRL 8-K 37780
  Complete submission text file 0001104659-25-051136.txt   241929

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20250516.xsd EX-101.SCH 3253
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20250516_def.xml EX-101.DEF 26568
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20250516_lab.xml EX-101.LAB 36010
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20250516_pre.xml EX-101.PRE 25183
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2515582d1_8k_htm.xml XML 4302
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 25970461
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)